Research Summaries

Researchers tested the effects of testosterone therapy on the risk of MI in older men, revealing some unexpected findings.

The FDA has approved two new drugs for the treatment of two rare conditions: peripheral T-cell lymphoma and Glanzmann's thrombasthenia.

By Reuters Staff ...

The FDA is mandating that manufacturers include a general warning on the drug labeling of all approved testosterone products to advise of the risk of blood clots.

An implant originally approved to treat certain patients with macular edema is now also approved for patients with diabetes.

The FDA has approved Afrezza, an inhaled insulin device for use in patients with type 1 and type 2 diabetes.

Rare, but serious allergic reactions, including swelling of the face, lips, tongue, eyes, and dyspnea, have been reported.

...

Adults with Asperger Syndrome (AS) are more likely to experience thoughts of suicide.

Regular exercise may enhance the benefits of testosterone in men with late-onset hypogonadism, according to a new study.